Latest News by Industry
NOVAVAX INC [NVAX] has reported fiscal Q1 loss of $294 million.
On a per-share basis, the DE based company said its diluted earnings are $3.41.
The Biological Products, Except Diagnostic Substances firm posted revenue of $81 million in this period.
Also Read:
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.